# Evo DNA Agent

**ID:** `biomedical.foundation_models.evo_dna`
**Version:** 1.0.0
**Status:** Production
**Category:** Foundation Models / DNA Sequence AI
**Released:** December 2025

---

## Overview

The **Evo DNA Agent** provides access to Evo, a DNA foundation model that can process information across molecular biology's central dogma - from DNA to RNA to proteins. Evo represents a breakthrough in understanding and generating biological sequences at the nucleotide level.

### Key Capabilities

| Task | Description | Performance |
|------|-------------|-------------|
| **Variant Effect** | Predict mutation effects | Top-tier |
| **Sequence Generation** | Generate functional DNA | State-of-art |
| **Gene Annotation** | Identify coding regions | High accuracy |
| **Regulatory Prediction** | Promoter/enhancer activity | Strong |

---

## Key Features

### 1. Central Dogma Modeling

```
DNA Sequence ──► Evo Model ──► Predictions
     │                              │
     ├── Coding regions             ├── Gene expression
     ├── Regulatory elements        ├── Protein function
     ├── Non-coding RNA             ├── Variant effects
     └── Genome structure           └── Synthetic design
```

### 2. Applications

| Domain | Use Case | Capability |
|--------|----------|------------|
| **Genomics** | Variant interpretation | VEP scoring |
| **Synthetic Biology** | DNA design | Sequence generation |
| **Gene Therapy** | Promoter optimization | Expression prediction |
| **Diagnostics** | Non-coding variants | Regulatory effect |

---

## Usage

### Example Prompt

```text
Analyze this genomic variant for potential pathogenic effects:

Variant: chr17:7579472 G>A (TP53 intron 6)
Context: Suspected hereditary cancer syndrome patient

Predict:
1. Splicing impact
2. Regulatory effect
3. Overall pathogenicity score
```

### Expected Output

```markdown
## Evo DNA Analysis: TP53 Intronic Variant

### Variant Information
| Property | Value |
|----------|-------|
| Location | chr17:7579472 |
| Gene | TP53 |
| Region | Intron 6 |
| Change | G>A |

### Evo Predictions

| Analysis | Score | Interpretation |
|----------|-------|----------------|
| Splicing Impact | 0.82 | High - potential cryptic splice site |
| Regulatory Effect | 0.34 | Low |
| Conservation | 0.91 | Highly conserved |
| **Pathogenicity** | **0.78** | **Likely Pathogenic** |

### Mechanistic Insight

```
Predicted Effect: Cryptic splice acceptor activation
├── Creates AG dinucleotide in intronic context
├── May cause partial intron retention
├── Expected result: Truncated/non-functional p53
└── Clinical relevance: Li-Fraumeni spectrum
```

### Recommendations
1. RNA analysis to confirm splicing effect
2. Consider functional studies
3. Cascade genetic testing for family
```

---

## LLM Agent Integration

### Python Tool

```python
from typing import Dict, Any, Optional

def evo_dna_tool(
    sequence: str,
    task: str = "predict",
    variant: Optional[str] = None,
    model_size: str = "large"
) -> Dict[str, Any]:
    """
    Evo DNA foundation model for sequence analysis.

    Args:
        sequence: DNA sequence (ACGT)
        task: 'predict', 'generate', 'variant', 'annotate'
        variant: Variant notation if task='variant'
        model_size: 'base' or 'large'

    Returns:
        Task-specific predictions
    """
    from evo import EvoModel

    model = EvoModel.from_pretrained(f"evo-{model_size}")

    if task == "variant":
        result = model.predict_variant_effect(sequence, variant)
    elif task == "generate":
        result = model.generate_sequence(sequence, max_length=1000)
    elif task == "annotate":
        result = model.annotate_features(sequence)
    else:
        result = model.predict(sequence)

    return result
```

---

## References

1. **Evo (2024)**: "Evo: a DNA foundation model for the central dogma." *bioRxiv*.
2. **Arc Institute**: [https://arcinstitute.org/](https://arcinstitute.org/)

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu

---

*Last updated: December 2025*
